Drug Topics
MARCH 14, 2025
A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress failure to pass PBM reform at the end of 2024.
PhRMA
MARCH 12, 2025
Health care practitioners (HCPs), and patients too, are sounding the alarm on unnecessary barriers in the system that can negatively impact patients’ access to quality care according to a new survey of HCPs and patients. Specifically, HCPs raised concerns over how pharmacy benefit managers (PBMs) and insurers inappropriately use utilization management tools, like prior authorization, to deny or delay care, ultimately harming the patient and impacting patient access to care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 18, 2025
Private equity firms are acquiring facilities that care for people with intellectual or developmental disabilities at an alarming rate, according to a new report released Tuesday. The care industry for this population has been historically owned and operated by nonprofits and faith-based institutions. However, between 2013 and 2023, private equity firms made over 1,000 acquisitions of disability and elder care providers — a likely undercount, according to the report published by the Priva
PharmaVoice
MARCH 10, 2025
Familiar foes in the industry have claimed a slew of jobs in recent months.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Guardian - Pharmaceutical Industry
MARCH 22, 2025
Nuffield Trust says supply chains have shifted, with drugs for epilepsy and cystic fibrosis among those now scarce Drug shortages in the UK have risen to their worst level for four years, official figures show, with Brexit considered a key reason so many medications are scarce. Drug companies notified the Department of Health and Social Care (DHSC) about disruptions to supply 1,938 times during last year the highest number since the 1,967 seen in 2021.
The Checkup by Singlecare
MARCH 7, 2025
On March 4, 2025, the U.S. Food and Drug Administration (FDA) announced its approval of the first generic form of Xarelto (rivaroxaban), a popular anticoagulant medication. The approval is for the 2.5 mg tablets prescribed to reduce the risk of major cardiovascular events in adults with coronary artery disease (CAD) and to reduce the risk of major thrombotic vascular events in adults with peripheral artery disease (PAD).
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PhRMA
MARCH 17, 2025
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c
STAT
MARCH 27, 2025
When I was secretary of the Department of Health and Human Services under President Bill Clinton, an agency head came to me with a dramatic reorganization plan. I advised him that unless it was data- and outcome-driven, he was wasting his time. Just as important, the reorganization would unsettle and confuse his new colleagues. As a result, his legacy would be a new structure rather than improving people’s lives.
PharmaVoice
MARCH 21, 2025
Pharma has long been considered “recession proof,” but an economic downturn could still hurt the industry in numerous ways.
Med Ed 101
MARCH 12, 2025
SM is a 48-year-old female who has new-onset symptoms of restlessness, irritability, insomnia, and vivid nightmares. Over the past 3 months, she has also experienced increasing anxiety and mood swings. She reports a feeling of impending doom and difficulty concentrating, which has begun to affect her daily life and work performance. She has a past […] The post Montelukast Causes The Prescribing Cascade – Case Study appeared first on Med Ed 101.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Checkup by Singlecare
MARCH 18, 2025
Raspberries are vibrant, juicy, and somewhat tart berries known for their rich fiber and antioxidant content. The berries are plucked and enjoyed as a healthy snack or topping on oatmeal and yogurt. But did you know that the leaves of the raspberry plant ( Rubus idaeus ) may have health benefits, too? You may have heard of red raspberry leaf tea. It is a caffeine-free herbal tea made from the dried leaves of the fruit-bearing plant.
Drug Topics
MARCH 4, 2025
If CMS doesnt reconsider its mandate, which forces independent pharmacies to go deep into a hole and lose money, many of them will close.
PhRMA
MARCH 6, 2025
Lawmakers on both sides of the aisle are renewing a multi-year effort to crack down on drug middlemen, known as pharmacy benefit managers (PBMs). These middlemen control what patients pay at the pharmacy counter, where they can get their medicine, what medicines they can get and what hoops they must jump through. The effort in Congress reflects mounting pressure to hold PBMs accountable and help lower patients’ out-of-pocket costs.
STAT
MARCH 31, 2025
I will never forget stepping into the cadaver lab for the first time. As the doors swung open, a sharp, sour wave of formaldehyde hit me and made my stomach churn. I pulled my thin polyester scrub shirt over my nose, but it did little to block the smell, let alone shield me from the bone-chilling temperature. Steel tables surrounded me, each holding a body, and I could see grayish-yellow skin peeking out from beneath the white drapes.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
MARCH 3, 2025
Consumers want more from biopharma. Next-generation direct-to-patient programs can deliver.
Pharma Marketing Network
MARCH 27, 2025
The Healthcare Businesswomens Association (HBA) has proudly announced its 2025 class of Rising Star and Luminary honorees! Nominated by the HBAs Corporate Partners, these leaders are not only exceptional contributors within their companies but also powerful advocates for health equity and women’s advancement globally, significantly contributing to the HBAs vision of Creating Women Leaders for Life.
Pharmacy Times
MARCH 21, 2025
The study aims to address lingering public concerns, but its findings and communication have the potential to impact vaccine confidence and public health efforts.
Drug Topics
MARCH 13, 2025
US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PhRMA
MARCH 24, 2025
A new report by the Wall Street Journal reveals abuse of the 340B hospital markup program is getting worse as hospitals and middlemen find new ways to profit off the program.
STAT
MARCH 31, 2025
Dana, a 29-year-old nurse in St. Louis, checks her phone to see if the gig nursing app CareRev still has her scheduled at the local hospital. She’s already arranged child care for her son, but cancellations are common. “It’s a gamble. … I’ll wake up at 5 in the morning, and I’ll find out if I’m canceled or not,” she told us.
PharmaVoice
MARCH 10, 2025
Experts say cost and other barriers present challenges to returning to U.S. shores.
The Checkup by Singlecare
MARCH 10, 2025
Weight loss pills have long been popular. More recently, there has been an unprecedented focus on new weight loss drugs with the same active ingredient: semaglutide. This glucagon-like peptide-1 ( GLP-1 ) receptor agonist is the active ingredient in Wegovy , Rybelsus, and Ozempic the last of which has become a household name after countless celebrities spread the word that it helped them lose weight.
Pharmacy Times
MARCH 20, 2025
Panelists discuss how antibody-drug conjugates (ADCs) often show more diverse outcomes in real-world settings compared with clinical trials, with varying efficacy and adverse effect profiles. Key practical considerations for pharmacists include appropriate dosing based on patient factors, managing drug interactions, implementing premedication protocols to minimize adverse reactions, and providing comprehensive supportive care.
Drug Topics
MARCH 31, 2025
Jean-Venable Goode, BSPharm, PharmD, and Jeff Goad, PharmD, MPH, presented on the most notable vaccine updates from the past year and how they impact pharmacy practice.
PhRMA
MARCH 18, 2025
The United States leads the world in the research, development and manufacturing of innovative medicines. But the Inflation Reduction Act’s (IRA) “pill penalty” puts this leadership at risk by discouraging the development of treatments that often come in pill form like a tablet or capsule, also known as small molecule medicines. Under the IRA, these treatments can be price set years before other medicines, signaling to researchers that developing them is not worth the risk.
STAT
MARCH 27, 2025
In what one U.S. lawmaker described as possibly the “largest tax-dodging scheme” by a pharmaceutical company in history, Pfizer sold $20 billion in medicines to U.S. customers six years ago, but did not report any profits from those sales on its 2019 tax returns because all of the income was supposedly earned offshore, according to an investigation by the Democratic staff of the Senate Finance Committee.
PharmaVoice
MARCH 31, 2025
The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.
The Checkup by Singlecare
MARCH 7, 2025
Baclofen is a muscle relaxant often prescribed to treat muscle spasms. Its often prescribed for people with muscle spasticity or tightness from multiple sclerosis , cerebral palsy, or certain types of spinal cord injuries. If you are taking baclofen, you might wonder whether its safe to drinkespecially if youre heading to an event where alcohol will be served.
Pharmacy Times
MARCH 3, 2025
Panelists discuss how pharmacists employ multiple strategies to support medication adherence in older adults with TD, including simplifying dosing regimens, utilizing medication synchronization programs, providing medication packaging solutions, conducting regular follow-up calls, and collaborating closely with prescribers and care teams to develop and adjust personalized treatment plans that address individual patient needs and barriers to care.
Drug Topics
MARCH 27, 2025
Tom DePietro, PharmD, owner of DePietro's Pharmacy, discusses how his pharmacy served their community during the COVID-19 pandemic.
Pharma Marketing Network
MARCH 12, 2025
Table of Contents Why Keyword Research for PPC Matters in Pharma Marketing Understanding Pharma-Specific PPC Challenges Best Practices for Pharma Keyword Research Optimizing PPC Campaigns for Compliance and ROI Why Keyword Research for PPC Matters in Pharma Marketing Keyword research for PPC is the foundation of any successful pharma marketing strategy.
STAT
MARCH 27, 2025
WASHINGTON — Around 3,500 employees are on the chopping block at the Food and Drug Administration, but they don’t yet know who they are. The Health and Human Services Department on Thursday announced a sweeping plan to cut 10,000 jobs and consolidate operations across its sub-agencies. FDA drug, medical device, or food reviewers and inspectors will not be among those fired, according to an HHS fact sheet.
PharmaVoice
MARCH 13, 2025
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.
Expert insights. Personalized for you.
574 
Let's personalize your content